Evidence map›Paper›PMID 30102819›Full record

ArticleBJOG : an international journal of obstetrics and gynaecology2019

Fetal microchimerism by mode of delivery: a prospective cohort study.

R Shree, W E Harrington, S B Kanaan, A Forsyth, E Cousin, A Lopez, J L Nelson, H S Gammill

Abstract readComparative Study
In one paragraph

Article in BJOG : an international journal of obstetrics and gynaecology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Presence of fetal microchimerisms in the heart and effect on cardiac repair.Frontiers in cell and developmental biology · 2024
    Article
  2. Article
  3. Umbilical Cord Maternal Microchimerism in Normal and Preeclampsia Pregnancies.Reproductive sciences (Thousand Oaks, Calif.) · 2023
    Article
  4. Increased fetal microchimerism in immune and stem cell subsets in preeclampsia.American journal of reproductive immunology (New York, N.Y. : 1989) · 2023
    Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

R ShreeDivision of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, University of Washington, Seattle, WA, USA.
W E HarringtonDepartment of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, WA, USA.
S B KanaanClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
A ForsythClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
E CousinClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
A LopezDepartment of Obstetrics and Gynecology, University of Washington, Seattle, WA, USA.
J L NelsonClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
H S GammillDivision of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, University of Washington, Seattle, WA, USA.
Fred Hutch Cancer Center · USUniversity of Washington · USSeattle Children's Hospital · US

Funding

ACADEMIC PEDIATRIC INFECTIOUS DISEASET32HD007233 · NICHD · SEATTLE CHILDREN'S HOSPITAL · PI KEVIN B URDAHL · 1985 to 2026
$6.7M
Microchimerism as AlloImmunityR01HL117737 · NHLBI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI NELSON, J. LEE · 2014 to 2018
$2.4M
The Maternal Anti-fetal Immune Response & Role of Microchimerism in PreeclamsiaK08HD067221 · NICHD · UNIVERSITY OF WASHINGTON · PI GAMMILL, HILARY SEGLIN · 2012 to 2016
$644k
NHLBI NIH HHS R01 HL117737NICHD NIH HHS K08 HD067221NIH HHS K08HD067221NIH HHS R01HL11737NIH HHS T32 HD007233
6 · The paper itself

Abstract

objectiveTo compare fetal microchimerism (FMc) in pregnancies with uncomplicated vaginal delivery (VD) versus caesarean delivery (CD).

designProspective cohort study.

settingUniversity of Washington and Fred Hutchinson Cancer Research Center, USA. POPULATION: Women delivering singleton pregnancies without pertinent antenatal complications with uncomplicated deliveries (n = 36).

methodsWe collected maternal predelivery, postdelivery and umbilical cord blood for each mother-baby pair. Following maternal and fetal genotyping, FMc was measured with quantitative polymerase chain reaction assays targeting fetus-specific polymorphisms. Quantification of FMc is expressed as genome equivalents (gEq) of fetal DNA/100 000 total gEq tested. FMc detection was evaluated by logistic regression while controlling for total number of cell equivalents tested and clinically relevant covariates. FMc concentrations were compared using negative binomial regression while controlling for the same covariates and predelivery FMc positivity.

main outcome measureDetection and concentration of FMc by mode of delivery.

resultsTwenty-four mother-baby pairs had a VD and 12 had a CD. Postdelivery FMc detection was higher following CD than after VD (58.3% versus 16.7%, P = 0.02). After controlling for covariates, the likelihood of postdelivery FMc detection was almost nine-fold higher after CD than VD (odds ratio 8.8, 95% CI 1.6-47.6; P = 0.01). With respect to postdelivery FMc concentration, the detection rate ratio for CD versus VD in the adjusted negative binomial regression model was 14.7 (95% CI 3.2-66.8; P = 0.001).

conclusionPostdelivery peripheral FMc detection and concentration are significantly higher after CD than after VD. As FMc is associated with long-term maternal health, our findings suggest that the mode of delivery may impact this risk. TWEETABLE ABSTRACT: Greater fetal microchimerism found in maternal blood following caesarean delivery compared with vaginal delivery.

Indexed as

ChimerismFetusAdultCesarean SectionDelivery, ObstetricFemaleFetal BloodHLA AntigensHumansMaternal-Fetal ExchangePregnancyProspective StudiesReal-Time Polymerase Chain ReactionRisk FactorsHLA AntigensCaesarean deliverymaternal-fetal exchangemicrochimerismmode of deliverypregnancy

Identifiers

PMID30102819
PMCPMC6294652
OpenAlexW2886994063

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.